Background The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coronavirus disease (COVID-19) and their correlation with the disease severity remain unclear. Methods Peripheral blood samples were longitudinally collected from 40 confirmed COVID-19 patients and examined for lymphocyte subsets by flow cytometry and cytokine profiles by specific immunoassays. Findings Of the…
EBioMedicine Template
Write in a clean editor, then format for EBioMedicine in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the EBioMedicine format
EBioMedicine is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, Gut microbiota and health, COVID-19 Clinical Research Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, EBioMedicine 12 (2023) 45–58.
Formats any DOI in EBioMedicine style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Gut microbiota and health COVID-19 Clinical Research Studies HIV Research and Treatment Epigenetics and DNA Methylation |
| ISSN | 2352-3964 |
| Citation impact (2-yr) | 9.39 |
| h-index | 181 |
| i10-index | 3,979 |
| Total citations | 253,057 |
| Article processing charge | $3,500 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in EBioMedicine per year
Citation impact of EBioMedicine by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in EBioMedicine
A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type 2 diabetes. However, reports vary regarding the association of particular taxonomic groups with disease. In this systematic review, we focused on the potential role of different bacterial taxa affecting diabetes. We have summarized evidence from 42…
BACKGROUND: Senescent cells, which can release factors that cause inflammation and dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with ageing and at etiological sites in multiple chronic diseases. Senolytics, including the combination of Dasatinib and Quercetin (D + Q), selectively eliminate senescent cells by transiently disabling pro-survival networks that defend them against their own apoptotic…
BACKGROUND: Public trust in immunization is an increasingly important global health issue. Losses in confidence in vaccines and immunization programmes can lead to vaccine reluctance and refusal, risking disease outbreaks and challenging immunization goals in high- and low-income settings. National and international immunization stakeholders have called for better monitoring of vaccine confidence to identify emerging…
The search for reliable indicators of biological age, rather than chronological age, has been ongoing for over three decades, and until recently, largely without success. Advances in the fields of molecular biology have increased the variety of potential candidate biomarkers that may be considered as biological age predictors. In this review, we summarize current state-of-the-art…